Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia.
Thomas, X
Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia. [electronic resource] - Leukemia Sep 1998 - 1503-6 p. digital
Publication Type: Case Reports; Letter; Comment
0887-6924
10.1038/sj.leu.2401126 doi
Adult
Aged
Amsacrine--administration & dosage
Antibiotics, Antineoplastic--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Body Mass Index
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Female
Heart--drug effects
Heart Failure--chemically induced
Humans
Leukemia, Promyelocytic, Acute--complications
Male
Mercaptopurine--administration & dosage
Obesity--complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Remission Induction
Tretinoin--administration & dosage
Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia. [electronic resource] - Leukemia Sep 1998 - 1503-6 p. digital
Publication Type: Case Reports; Letter; Comment
0887-6924
10.1038/sj.leu.2401126 doi
Adult
Aged
Amsacrine--administration & dosage
Antibiotics, Antineoplastic--adverse effects
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Body Mass Index
Cytarabine--administration & dosage
Daunorubicin--administration & dosage
Female
Heart--drug effects
Heart Failure--chemically induced
Humans
Leukemia, Promyelocytic, Acute--complications
Male
Mercaptopurine--administration & dosage
Obesity--complications
Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy
Remission Induction
Tretinoin--administration & dosage